Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Adaptimmune

Biotech & Life Sciences · Milton, United Kingdom · Founded 2008 · IPO 2015 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$57M
Market cap · 2026
Revenue
$178M
Latest reported FY

Investors

13 investors on Adaptimmune's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 11 investors entered at this stage
venBio Partners
Ridgeback Capital
Wellington Management
OrbiMed
MPM BioImpact
Merlin Nexus
Novo Holdings
F-Prime
NEA
Rock Springs Capital
Foresite Capital
Series B+ 2 investors entered at this stage
Oxford University Innovation
University of Oxford

Global footprint

Where Adaptimmune has talent and traffic

Web traffic by country
7.5K monthly visits
across markets
🇺🇸 United States45.3%
🇬🇧 United Kingdom32%
🇮🇳 India13.3%
🇨🇦 Canada5.3%
🇯🇵 Japan2.7%
Top 5 markets shown

See Adaptimmune on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo